Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Ravelcare IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Ravelcare Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹10.5 and post-issue EPS of ₹7.66 for FY25. The pre-issue P/E ratio is 12.38x,while the post-issue P/E ratio is 16.97x against the Industry P/E ratio is NA The company's ROE for FY25 is 68.04% and RoNW is 50.77% The Annualised EPS is ₹9.32x and P/E is
13.95x. These metrics suggest that the IPO is Fully priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 10.5 |
| EPS Post IPO (Rs.) | 7.66 |
| Adjusted 12M EPS Post IPO (Rs.) | 9.32 |
| P/E Pre IPO | 12.38 |
| P/E Post IPO | 16.97 |
| Adjusted 12M P/E Post IPO | 13.95 |
| ROE | 68.04% |
| ROCE | 68.32% |
| P/BV | 6.29 |
| Debt/Equity | - |
| RoNW | 50.77% |
| EBITDA Margin | 27.30% |
| PAT Margin | 20.77% |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
